Lisburn woman in ovarian cancer diagnostic firm wins £50,000 at top innovation awards

A leading female researcher at Queen’s University commercial spin-out, GenoME Diagnostics, has won £50,000 and a mentoring and support package after being named a winner at Innovate UK’s Women in Innovation Awards.

Dr Shannon Beattie from Hillsborough is chief operating officer of GenoME Diagnostics — a spin out company from the Patrick G Johnston Centre in Queen’s University Belfast, established in 2020. It is built on over a decade of academic research, primarily by its three key founders Dr Mullan, Dr Beirne and Dr Feeney.

The business is using cutting-edge technology to develop a user-friendly, accurate and cost-effective diagnostic test for ovarian cancer, a disease often only ever detected in later stages.

GenoME Diagnostics’ lead product, OvaME, is the novel blood test for earlier and more accurate detection of ovarian cancer, specifically High Grade Serous Carcinoma (HGSC). It is currently undergoing the necessary validation for regulatory approval with the goal to enter the public health system as a disease monitoring tool.

Read the full article on the Newsletter website